Mevalonate pathway activity as a determinant of radiation sensitivity in head and neck cancer

Radioresistance is a major hurdle in the treatment of head and neck squamous cell carcinoma (HNSCC). Here, we report that concomitant treatment of HNSCCs with radiotherapy and mevalonate pathway inhibitors (statins) may overcome resistance. Proteomic profiling and comparison of radioresistant to rad...

Descripción completa

Detalles Bibliográficos
Autores principales: Ricco, Natalia, Flor, Amy, Wolfgeher, Don, Efimova, Elena V., Ramamurthy, Aishwarya, Appelbe, Oliver K., Brinkman, Jacqueline, Truman, Andrew W., Spiotto, Michael T., Kron, Stephen J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6717759/
https://www.ncbi.nlm.nih.gov/pubmed/31225926
http://dx.doi.org/10.1002/1878-0261.12535

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6717759/
https://www.ncbi.nlm.nih.gov/pubmed/31225926
http://dx.doi.org/10.1002/1878-0261.12535

Ejemplares similares